Recently, in order to implement the “Central Committee of the Communist Party of China” The spirit of policies such as the Opinions of the State Council on Supporting Shenzhen in Building a Pioneer Demonstration Zone of Socialism with Chinese Characteristics” and “Shenzhen City’s Implementation Plan on Further Accelerating the Development of Strategic Emerging Industries” (Shenfu [2018] No. 84) fully connect with the “Shenzhen City Promotion Plan” “Guiding Opinions on Promoting the Cluster Development of the Biomedical Industry” and related supporting documents (Shenzhen Fuban [2020] No. 2), accelerate the development of the city’s biomedical industry, and strive to build a domestically leading and world-class biomedical industry development highland, Shenzhen Municipal Development and Reform Commission studied and drafted “Several Measures to Promote the Development of Biopharmaceutical Industry Clusters in Shenzhen (Draft for Comment)”.
It is highlighted in “Measures” that For core technologies such as gene therapy drugs and cell therapy drugs, we support enterprises to work with universities and scientific research institutes to carry out “stuck neck” technological research, and provide up to 300 million yuan in funding.
Key points in “Measures” that deserve our attention:
General requirements of the “Measures”, Focus on supporting the development of innovative drugs and biotechnology, focusing on…cell therapy drugs, gene therapy drugs, new vaccines…personalized treatment technologies and other directions.
Consolidate industrial infrastructure construction capabilities
Financial subsidies will be provided to those undertaking major national technological research and technological transformation tasks, and striving for the implementation of major national scientific and technological infrastructure.
Lay out and enhance provincial and municipal major industry service platforms
